经尿道双极等离子电切术治疗前列腺增生症(附276例报告)

Transurethral plasmakinetic resection of prostate for the treatment of benign prostate hyperplasia(276 cases)

目的探讨经尿道双极等离子电切术(PKRP)治疗前列腺增生症(BPH)的疗效。方法采用PKRP治疗前列腺增生症276例,随访3～15个月。结果平均手术时间72min;术后平均留置导尿管4.2d,术后平均住院时间5.6d;最大尿流率(Qmax)由术前的(6.1±1.3)mL/s上升至术后3个月的(19.7±4.6)mL/s(P<0.01),前列腺症状评分(IPSS)由术前的(24.5±5.8)分下降至术后3个月的(6.3±0.7)分(P<0.01),生活质量评分(QOL)亦得到了显著改善。结论PKRP治疗前列腺增生症疗效好,并发症少,手术安全。

[Objective] In order to evaluate the validity of transurethral plasmakinetic resection of prosate （PKRP） for the treatment of benign prostatic hyperplasia （BPH）. [Methods] 276 cases of BPH were treated by PKRP and had been followed up at 3 and 15 months, [Resuls] The mean operative time was 72 rain. The mean catheterization time was 4.2 days and the mean postoperative hospital stay was 5.6 days.The peak flow rate of urine increased from （6.1±1.3） mL/s to （19.7±4.6） mL/s and the international prostate symptom score （IPSS） decreased from （24.53±5.8） to （6.3±0.7） at 3 months posoperatively （P 〈0.01）, and the QOL of all the eatanmeses significantly improved. [Conclusion] PKRP is a safe and effective optative method with less eomplieations for the treatment of symptomatic BPH.